| Literature DB >> 35204388 |
Rui Li1, Chuda Xiao1, Yongzhi Huang1, Haseeb Hassan1,2,3, Bingding Huang1.
Abstract
Lung cancer has one of the highest mortality rates of all cancers and poses a severe threat to people's health. Therefore, diagnosing lung nodules at an early stage is crucial to improving patient survival rates. Numerous computer-aided diagnosis (CAD) systems have been developed to detect and classify such nodules in their early stages. Currently, CAD systems for pulmonary nodules comprise data acquisition, pre-processing, lung segmentation, nodule detection, false-positive reduction, segmentation, and classification. A number of review articles have considered various components of such systems, but this review focuses on segmentation and classification parts. Specifically, categorizing segmentation parts based on lung nodule type and network architectures, i.e., general neural network and multiview convolution neural network (CNN) architecture. Moreover, this work organizes related literature for classification of parts based on nodule or non-nodule and benign or malignant. The essential CT lung datasets and evaluation metrics used in the detection and diagnosis of lung nodules have been systematically summarized as well. Thus, this review provides a baseline understanding of the topic for interested readers.Entities:
Keywords: deep learning; lung cancer; lung nodule computer-aided diagnosis; lung nodule segmentation and classification
Year: 2022 PMID: 35204388 PMCID: PMC8871398 DOI: 10.3390/diagnostics12020298
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1A general pipeline of a lung nodule CAD system.
Cited datasets and their composition.
| Dataset | The Number of CT Scans | The Number of Nodules | Annotation |
|---|---|---|---|
| LIDC-IDRI | 1018 | 36,378 | √ |
| LUNA16 | 888 | 13,799 | √ |
| Ali Tianchi | 1000 | 1000 | √ |
| NSCLC | 211 | - | √ |
| ELCAP | 50 | - | √ |
| ANODE09 | 55 (only 5 CT scans) | 39 | √ |
Various evaluation metrics used for lung cancer/nodule diagnosis.
| Metric | Brief | Expression |
|---|---|---|
| Sensitivity (SEN) | Measures the proportion of positives that are correctly identified |
|
| Accuracy (ACC) | Classification accuracy of the classifier |
|
| Positive predictive value (PPV) | The proportions of positive results in statistics and diagnostic tests that are truly positive |
|
| Dice Similarity Coefficient (DSC) | A statistics used to gauge the similarity of two samples. |
|
| Intersection over Union (IoU) | The IoU measurement gives the similarity between the predicted area and the real area of the objects present in the set of images |
|
| F1-Score | Used in statistics to measure the accuracy of a binary classification model |
|
| Receiver Operating Characteristic (ROC) | A curve depicting the relationship between the sensitivity and specificity (Y-axis is TP rate and | - |
| Free Receiver Operating Characteristic (FROC) | Similar to the ROC curve, differing only in the | - |
| Area Under Curve (AUC) | Total area under the ROC curve | - |
| Competition Performance Metric (CPM) | Average of the Sensitivity at seven defined FP rates in the FROC curve: 1/8,1/4,1/2,1,2,4,8 FPs/scan | - |
| Mean Average Precision (mAP) | Mean Average Precision | - |
Note: TP: true positive; TN: true negative; FN: false negative; FP: false positive.
Figure 2Network architecture of lung nodule segmentation.
Deep learning-based lung nodule segmentation architectures and their key information.
| Study | Year | Architecture | Dataset | Approach | Performance |
|---|---|---|---|---|---|
| Pezzano et al. [ | 2021 | CoLe-CNN | LIDC-IDRI | 2D | F1 = 86.1 |
| Dong et al. [ | 2020 | MV-SIR | LIDC-IDRI | 2D/3D | ASD = 7.2 ± 3.3 |
| Keetha et al. [ | 2020 | U-DNet | LUNA16 | 2D | DSC = 82.82 ± 11.71 |
| Cao et al. [ | 2020 | DB-ResNet | LIDC-IDRI | 2D/3D | DSC = 82.74 ± 10.19 |
| Kumar el al. [ | 2020 | V-Net | LUNA16 | 3D | DSC = 96.15 |
| Usman et al. [ | 2020 | Adaptive ROI with Multi-view Residual Learning | LIDC-IDRI | 2D/3D | SEN = 91.62 |
| Tang et al. [ | 2019 | NoduleNet | LIDC-IDRI | 3D | DSC = 83.10 |
| Huang et al. [ | 2019 | Faster R-CNN | LUNA16 | 2D | ACC = 91.4 |
| Aresta et al. [ | 2019 | iW-Net | LIDC-IDRI | 3D | IoU = 55 |
| Hesamian et al. [ | 2019 | Atrous convolution | LIDC-IDRI | 2D | DSC = 81.24 |
| Liu et al. [ | 2018 | Mask R-CNN | LIDC-IDRI | 2D | 73.34 mAP |
| Khosravan et al. [ | 2018 | Semi-supervised multitask learning | LUNA16 | 3D | SEN = 98 |
| Wu et al. [ | 2018 | PN-SAMP | LIDC-IDRI | 3D | DSC = 73.98 |
| Tong et al. [ | 2018 | Improved U-NET network | LUNA16 | 2D | DSC = 73.6 |
| Zhao et al. [ | 2018 | 3D U-Net and Contextual Convolutional Neural Network | LIDC-IDRI | 3D | None |
| Wang et al. [ | 2017 | MV-CNN | LIDC-IDRI | 2D/3D | SEN = 83.72 |
| Wang et al. [ | 2017 | CF-CNN | LIDC-IDRI/GDGH | 2D/3D | LIDC: |
Overview of lung nodule classification architectures and their key information.
| Year | Author | Method | Performance |
|---|---|---|---|
| 2021 | Ge Zhang [ | 3D DenseNet Dense block Transition layer Malignant or benign | ACC = 92.4% |
| 2020 | Akila Agnes [ | CNN 2D Malignant or benign | SEN = 81% |
| 2020 | Rekka Mastouri [ | BCNN 3D VGG16 VGG19 SVM Nodule or non-Nodule | ACC = 91.99% |
| 2020 | Hong Liu [ | MMEL-3DCNN VggNet ResNet InceptionNet Multinetwork Malignant or benign | SEN = 0.837% |
| 2020 | Kai Xia [ | Residual learning Dense learning MSAN GBM 3D attention Dual-path Malignant or benign | ACC = 91.9% |
| 2020 | Wu et al. [ | 2D Migration learning ResNet50 PCA Nodule or non-nodule | ACC = 98.23% |
| 2020 | Ali et al. [ | 2D Energy Layer Transfer learning Malignant or benign | ACC = 96.69% ± 0.72% |
| 2019 | Yang An [ | 2S-CNN Inception CNN Nodule or non-nodule | ACC = 89.6% |
| 2019 | Zhang Li [ | AlexNet SDS MPPS Malignant or benign | ACC = 93.68% |
| 2019 | Tran et al. [ | 2D Focal loss Nodule or non-nodule | ACC = 97.2% |
| 2019 | Al-Shabi et al. [ | 2D Residual block Non-Local block Self-attention Malignant or benign | AUC = 95.62% |
| 2019 | Al-Shabi et al. [ | 2D Multiple dilated convolutions Context-Aware sub-network Mid-range sized nodules Malignant or benign | AUC = 93.15% |
| 2019 | Guobin Zhang [ | SE-ResNeXt SENet ResNet Malignant or benign | AUC = 0.9563 |
| 2018 | Shiwen Shen [ | HSCNN 3D Sub-task Malignant or benign | AUC = 0.856 |
| 2018 | Dey et al. [ | 3D Multiscale Multioutput Dense block Malignant or benign | TPR = 90.47% |
| 2018 | Wu et al. [ | 3D 3D U-Net WW/WC | ACC = 97.58% |
| 2018 | Zhao et al. [ | 3D CNN Inception structure | None |
| 2017 | Nibali et al. [ | 2D ResNet18 Transfer learning Curriculum learning Malignant or benign | SEN = 91.07% |
| 2017 | Liu et al. [ | 2D Multiscale Multichannel Binary/Ternary classification Malignant or benign | SEN = 90.18% |
| 2016 | Li et al. [ | 2D CNN Multiscale Two networks Nodule or non-nodule | ACC = 86.4% |
| 2016 | Shen et al. [ | 3D CNN Multi-crop pooling layer Malignant score | ACC = 87.14% |
| 2015 | Kumar et al. [ | 2D CNN Binary decision tree Malignant or benign | ACC = 75.01% |
Results comparison of nodule segmentation models.
| Year | Author | Dataset | PPV (%) | SEN (%) | DSC (%) | IOU | Architecture | Approach |
|---|---|---|---|---|---|---|---|---|
| 2020 | Dong et al. [ | LIDC-IDRI | 93.6 | 98.10 | 92.6 | - | Multiview | |
| 2020 | Cao et al. [ | LIDC-IDRI | 79.64 | 89.35 | 82.74 | - | Multiview | |
| 2017 | Wang et al. [ | LIDC-IDRI | 77.59 | 83.72 | 77.67 | - | Multiview | |
| 2017 | Wang et al. [ | LIDC-IDRI/GDGH | 75.84 | 92.75 | 82.15 | - | Multiview | |
| 2017 | Shen et al. [ | Random datasets | 87.14 | 0.77 | - | - | MC-CNN | Multiview |
| 2021 | Pezzano et al. [ | LIDC-IDRI | - | - | - | 76.6 | Nodule type | General |
| 2020 | Keetha et al. [ | LUNA16 | 78.92 | 92.24 | 82.82 | - | U-Net et al. | General |
| 2020 | Kumar et al. [ | LUNA16 | - | - | 96.15 | - | U-Net et al. | General |
| 2020 | Usman et al. [ | LIDC-IDRI | 88.24 | 91.62 | 87.55 | - | General | |
| 2019 | Huang et al. [ | LUNA16 | - | - | 79.3 | - | U-Net et al. | General |
| 2018 | Wu et al. [ | LIDC-IDRI | - | - | 73.98 | - | U-Net et al. | General |
| 2018 | Tong et al. [ | LUNA16 | - | - | 73.6 | - | U-Net et al. | General |
| 2018 | Zhao et al. [ | LIDC-IDRI | - | - | - | - | U-Net et al. | General |
| 2018 | Liu et al. [ | LIDC-IDRI | - | - | - | - | FCN | General |
| 2019 | Aresta et al. [ | LIDC-IDRI | - | - | - | 55 | Nodule type | |
| 2019 | Hesamian et al. [ | LIDC-IDRI | - | - | 81.24 | - | - | |
| 2018 | Khosravan et al. [ | LUNA16 | - | 98 | 91 | - | semi-supervised | |
| 2019 | Tang et al. [ | LIDC-IDRI | - | - | 83.10 | - | - |
Results comparison of nodule classification models.
| Year | Reference | Dataset | SEN (%) | AUC (%) | ACC | Classification |
|---|---|---|---|---|---|---|
| 2021 | Ge Zhang [ | LUNA16 | 87.00 | - | 92.40 | MOB |
| 2020 | Akila Agnes [ | LIDC- IDRI | 81.00 | 94.40 | - | MOB |
| 2020 | Hong Liu [ | LIDC-IDRI | 0.837 | 93.90 | 90.60 | MOB |
| 2020 | Kai Xia [ | LIDC-IDRI | 91.30 | - | 91.90 | MOB |
| 2020 | Ali et al. [ | LIDC-IDRI | 98.10 | 99.11 | 96.69 | MOB |
| 2019 | Zhang Li [ | LIDC-IDRI | 95.17 | - | 93.68 | MOB |
| 2019 | Guobin Zhang [ | LUNA16 | - | 95.63 | 91.67 | MOB |
| 2019 | Al-Shabi et al. [ | LIDC-IDRI | 88.66 | 95.62 | 88.46 | MOB |
| 2019 | Al-Shabi et al. [ | LIDC-IDRI | 92.21 | 93.15 | 92.57 | MOB |
| 2018 | Shiwen Shen [ | LIDC-IDRI | 0.705 | 0.856 | 0.842 | MOB |
| 2018 | Dey et al. [ | LIDC-IDRI/Themselves dataset | - | 95.48 | 90.40 | MOB |
| 2017 | Nibali et al. [ | LIDC-IDRI | 91.07 | 94.59 | 89.90 | MOB |
| 2016 | Shen et al. [ | LIDC-IDRI | 77.00 | 93.00 | 87.14 | MOB |
| 2015 | Kumar et al. [ | LIDC-IDRI | 83.35 | - | 75.01 | MOB |
| 2020 | Wu et al. [ | LIDC-IDRI | 97.70 | - | 98.23 | NON |
| 2019 | Yang An [ | LIDC-IDRI | - | - | 89.60 | NON |
| 2019 | Tran et al. [ | LIDC-IDRI | 96.00 | - | 97.20 | NON |
| 2020 | Rekka Mastouri [ | LUNA16 | 91.85 | - | 91.99 | NON |
| 2018 | Wu et al. [ | LIDC-IDRI | - | - | 97.58 | NON |
| 2018 | Zhao et al. [ | LIDC-IDRI | - | - | - | NON |
| 2017 | Liu et al. [ | LIDC-IDRI | 90.18 | 98.10 | - | others |
| 2016 | Li et al. [ | LIDC-IDRI | 89.0 | - | 86.40 | others |
MOB: Malignant or benign; NON: nodule or non-nodule; Other: except MOB and NON.